2016
DOI: 10.1093/ijnp/pyw041.423
|View full text |Cite
|
Sign up to set email alerts
|

PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles